Optimizing the diagnostic timing for drug-resistant epilepsy: balancing timeliness and stability with an antiseizure medication waiting period
Therapeutic Advances in Neurological Disorders
Published online on July 06, 2026
Abstract
Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
Background:While drug-resistant epilepsy (DRE) is defined by the failure of two antiseizure medications (ASM), the optimal duration to confirm such resistance remains controversial. Clinical delays intended for treatment optimization may postpone life-...
Background:While drug-resistant epilepsy (DRE) is defined by the failure of two antiseizure medications (ASM), the optimal duration to confirm such resistance remains controversial. Clinical delays intended for treatment optimization may postpone life-...